XCUR
Exicure (XCUR)
$35
About Exicure (XCUR)
Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The firm's product pipeline includes Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Redwood City, CA.
Details
Daily high
$1.43
Daily low
$1.27
Price at open
$1.35
52 Week High
$9.48
52 Week Low
$1.27
Market cap
8.6M
Dividend yield
0.00%
Volume
39,990
Avg. volume
1.2M
P/E ratio
-.88
Exicure News
Details
Daily high
$1.43
Daily low
$1.27
Price at open
$1.35
52 Week High
$9.48
52 Week Low
$1.27
Market cap
8.6M
Dividend yield
0.00%
Volume
39,990
Avg. volume
1.2M
P/E ratio
-.88